PPD stock forecast
Our latest prediction for PPD, Inc.'s stock price was made on the Sept. 21, 2020 when the stock price was at 34.16$.
In the short term (2weeks), PPD's stock price should underperform the market by -1.01%. During that period the price should oscillate between -6.79% and +5.81%.
In the medium term (3months), PPD's stock price should underperform the market by -3.69%. During that period the price should oscillate between -22.75% and +15.09%.Get email alerts
Create a solid portfolio with PPD
About PPD, Inc.
PPD, Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.
At the moment the company generates 4154M USD in revenues.
On its last earning announcement, the company reported a profit of 0.08$ per share.
The book value per share is -7.93$
Three months stock forecastSept. 21, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|